FIELD: biotechnology, gene engineering, medicine.
SUBSTANCE: polypeptide (IL-li) is obtained by recombinant DNA technology having activity of interleukin-1-alpha and interleukin-1-beta inhibitor. Disclosed is DNA sequences encoding inhibitor precursor and maturated form thereof. Described is method for production of vector constructs containing said DNA sequences, as well as transformed cells producing of recombinant IL-li.
EFFECT: method for large-scale production of interleukin-1-beta inhibitor, useful in medicine.
21 cl, 26 dwg, 11 ex
Authors
Dates
2006-10-27—Published
1999-02-11—Filed